Dr Melvin Lobo, Pharmaceutical Medicine Specialist

Consultant Cardiovascular Physician and Clinical Hypertension Specialist

Member of the Royal College of Physicians
Member of the British Hypertension Society
Member of the British Pharmacological Society

Dr Melvin Lobo is a Consultant Pharmaceutical Medicine Specialist. He has a specialist interest in hypertension in all its forms, in particular resistant hypertension and device-based therapies thereof. He graduated from University of Manchester. He is an accredited Clinical Hypertension Specialist of the European Society of Hypertension (ESH).

Dr Melvin Lobo is Director of the Bart's Hypertension Clinic which is a Hypertension Centre of Excellence and receives referrals of complex hypertensive patients on a national/international basis. He has participated in several landmark studies in hypertension. He was a Principal Investigator of the symplicity HTN-2 study of renal denervation for treatment-resistant hypertension.

He is current joint Coordinating Investigator of the forthcoming global, multi-centre EnligHTN II Study and a Chief Investigator of the Rox Control Study of Resistant Hypertension. He organises and co-chairs the UK Annual Symposia on Renal Denervation with a distinguished panel of international authorities in hypertension medicine. He is an adviser to NICE on interventional therapies in hypertension and a member of the National Steering Committee on Renal Denervation which helped to create the UK National Renal Denervation Registry. He is also a member of the Royal College of Physicians, the British Hypertension Society and the British Pharmacological Society.

Dr Melvin Lobo has clinical expertise in hypertension, cardiovascular disease, circulatory disorders, general internal medicine and cardiovascular medicine.

Hypertension
Cardiovascular Disease
Circulatory Disorders
General Internal Medicine
Cardiovascular Medicine